1. Merck CEO Frazier says COVID vaccine hype a 'grave disservice' to the public — Why Inovio is the front runner in COVID vaccine development — Biogen and Eisai trial drug in asymptomatic Alzheimer's — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Pro vs Con?

Discussion in 'Pharmacyclics' started by anonymous, Jul 31, 2018 at 9:55 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Looking at a position here, any words or encouragement/caution? Thank you in advance for your comments
     

  2. anonymous

    anonymous Guest

    Pro: drug & base salary, (negotiate hard they are desperate.)
    Con: pods with another company, terrible vacation plan, weak bonus, no equity, indecisive leadership, multiple competitors coming to a team that fucks up when there is no competition now, always massive turnover in house and in the field.

    its a decent job to take if you are unemployed, not in oncology, or in a bad situation but it's not a good place to be long term.